Valvular Heart Disease
Calcified aortic valve disease (CAVD) affects over six million Americans and is associated with changes in the mechanical properties of valve leaflets, resulting in impaired valvular blood flow. CAVD is a fibrocalcific disease with multifactorial risk factors that are related to the complex environm...
Պահպանված է:
| Ձևաչափ: | Online |
|---|---|
| Լեզու: | անգլերեն |
| Հրապարակվել է: |
MDPI - Multidisciplinary Digital Publishing Institute
2025
|
| Խորագրեր: | |
| Առցանց հասանելիություն: | ONIX_20250812T095121_9783725828678_12 |
| Ցուցիչներ: |
Չկան պիտակներ, Եղեք առաջինը, ով նշում է այս գրառումը!
|
| _version_ | 1869517855339315200 |
|---|---|
| collection | Directory of Open Access Books |
| description | Calcified aortic valve disease (CAVD) affects over six million Americans and is associated with changes in the mechanical properties of valve leaflets, resulting in impaired valvular blood flow. CAVD is a fibrocalcific disease with multifactorial risk factors that are related to the complex environment where the aortic valve (AV) resides. This special issue focuses on the field of heart disease, exploring the relationship between heart valve disease, arrhythmia, kidney disease, and cardiovascular disease, as well as research progress on new treatment strategies and risk prediction. |
| format | Online |
| id | doab-20.500.12854ir-165063 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2025 |
| publishDateRange | 2025 |
| publishDateSort | 2025 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1650632025-08-12T07:58:17Z Valvular Heart Disease Bouchareb, Rihab aortic valve lipids statins Lp(a) PCSK9 NT-proBNP cardiogenic shock valve surgery extracorporeal membrane oxygenation (ECMO) aortic stenosis ACURATE neo2 left ventricular outflow tract hemodynamic performance computed tomography echocardiography prosthesis patient mismatch non-rheumatic calcific aortic valve disease (nrCAVD) global burden of disease prevalence disability-adjusted life-years (DALYs) socio-demographic index contribution factor improvement bioprosthesis replacement redo surgery structural valve degeneration endocarditis aortic valve replacement minimally invasive surgery sutureless valves animal model chronic kidney disease cardiovascular complications calcified aortic valve disease mitral valve surgery atrial fibrillation radiofrequency ablation heart failure rheumatic valve disease survival overweight obesity probiotics meta-analysis celecoxib NSAIDs COX-2 calcific aortic valve disease TAVI conduction disturbance pacemaker implantation membranous septum cancer valve replacement cardio-oncology transcatheter valve implantation radiation therapy mineralization magnetic resonance imaging dapagliflozin rheumatic heart disease mitral stenosis mitral valve MPG net atrioventricular compliance NT-pro BNP mitral regurgitation tricuspid regurgitation surgical aortic valve replacement aortic regurgitation progression sex calcification patient-prosthesis mismatch thema EDItEUR::M Medicine and Nursing Calcified aortic valve disease (CAVD) affects over six million Americans and is associated with changes in the mechanical properties of valve leaflets, resulting in impaired valvular blood flow. CAVD is a fibrocalcific disease with multifactorial risk factors that are related to the complex environment where the aortic valve (AV) resides. This special issue focuses on the field of heart disease, exploring the relationship between heart valve disease, arrhythmia, kidney disease, and cardiovascular disease, as well as research progress on new treatment strategies and risk prediction. 2025-08-12T07:58:15Z 2025-08-12T07:58:15Z 2025 book ONIX_20250812T095121_9783725828678_12 9783725828678 9783725828685 https://directory.doabooks.org/handle/20.500.12854/165063 eng image/jpeg Attribution 4.0 International https://mdpi.com/books https://mdpi.com/books/pdfview/book/10522 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-2868-5 10.3390/books978-3-7258-2868-5 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725828678 9783725828685 206 open access |
| spellingShingle | aortic valve lipids statins Lp(a) PCSK9 NT-proBNP cardiogenic shock valve surgery extracorporeal membrane oxygenation (ECMO) aortic stenosis ACURATE neo2 left ventricular outflow tract hemodynamic performance computed tomography echocardiography prosthesis patient mismatch non-rheumatic calcific aortic valve disease (nrCAVD) global burden of disease prevalence disability-adjusted life-years (DALYs) socio-demographic index contribution factor improvement bioprosthesis replacement redo surgery structural valve degeneration endocarditis aortic valve replacement minimally invasive surgery sutureless valves animal model chronic kidney disease cardiovascular complications calcified aortic valve disease mitral valve surgery atrial fibrillation radiofrequency ablation heart failure rheumatic valve disease survival overweight obesity probiotics meta-analysis celecoxib NSAIDs COX-2 calcific aortic valve disease TAVI conduction disturbance pacemaker implantation membranous septum cancer valve replacement cardio-oncology transcatheter valve implantation radiation therapy mineralization magnetic resonance imaging dapagliflozin rheumatic heart disease mitral stenosis mitral valve MPG net atrioventricular compliance NT-pro BNP mitral regurgitation tricuspid regurgitation surgical aortic valve replacement aortic regurgitation progression sex calcification patient-prosthesis mismatch thema EDItEUR::M Medicine and Nursing Valvular Heart Disease |
| title | Valvular Heart Disease |
| title_full | Valvular Heart Disease |
| title_fullStr | Valvular Heart Disease |
| title_full_unstemmed | Valvular Heart Disease |
| title_short | Valvular Heart Disease |
| title_sort | valvular heart disease |
| topic | aortic valve lipids statins Lp(a) PCSK9 NT-proBNP cardiogenic shock valve surgery extracorporeal membrane oxygenation (ECMO) aortic stenosis ACURATE neo2 left ventricular outflow tract hemodynamic performance computed tomography echocardiography prosthesis patient mismatch non-rheumatic calcific aortic valve disease (nrCAVD) global burden of disease prevalence disability-adjusted life-years (DALYs) socio-demographic index contribution factor improvement bioprosthesis replacement redo surgery structural valve degeneration endocarditis aortic valve replacement minimally invasive surgery sutureless valves animal model chronic kidney disease cardiovascular complications calcified aortic valve disease mitral valve surgery atrial fibrillation radiofrequency ablation heart failure rheumatic valve disease survival overweight obesity probiotics meta-analysis celecoxib NSAIDs COX-2 calcific aortic valve disease TAVI conduction disturbance pacemaker implantation membranous septum cancer valve replacement cardio-oncology transcatheter valve implantation radiation therapy mineralization magnetic resonance imaging dapagliflozin rheumatic heart disease mitral stenosis mitral valve MPG net atrioventricular compliance NT-pro BNP mitral regurgitation tricuspid regurgitation surgical aortic valve replacement aortic regurgitation progression sex calcification patient-prosthesis mismatch thema EDItEUR::M Medicine and Nursing |
| topic_facet | aortic valve lipids statins Lp(a) PCSK9 NT-proBNP cardiogenic shock valve surgery extracorporeal membrane oxygenation (ECMO) aortic stenosis ACURATE neo2 left ventricular outflow tract hemodynamic performance computed tomography echocardiography prosthesis patient mismatch non-rheumatic calcific aortic valve disease (nrCAVD) global burden of disease prevalence disability-adjusted life-years (DALYs) socio-demographic index contribution factor improvement bioprosthesis replacement redo surgery structural valve degeneration endocarditis aortic valve replacement minimally invasive surgery sutureless valves animal model chronic kidney disease cardiovascular complications calcified aortic valve disease mitral valve surgery atrial fibrillation radiofrequency ablation heart failure rheumatic valve disease survival overweight obesity probiotics meta-analysis celecoxib NSAIDs COX-2 calcific aortic valve disease TAVI conduction disturbance pacemaker implantation membranous septum cancer valve replacement cardio-oncology transcatheter valve implantation radiation therapy mineralization magnetic resonance imaging dapagliflozin rheumatic heart disease mitral stenosis mitral valve MPG net atrioventricular compliance NT-pro BNP mitral regurgitation tricuspid regurgitation surgical aortic valve replacement aortic regurgitation progression sex calcification patient-prosthesis mismatch thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20250812T095121_9783725828678_12 |